Volume 17, Number 10—October 2011
Dispatch
Clostridium difficile Infection in Outpatients, Maryland and Connecticut, USA, 2002–2007
Jon Mark Hirshon
, Angela D. Thompson, Brandi Limbago, L. Clifford McDonald, Michelle Bonkosky, Robert Heimer, James Meek, Volker Mai, and Christopher R. Braden
, Angela D. Thompson, Brandi Limbago, L. Clifford McDonald, Michelle Bonkosky, Robert Heimer, James Meek, Volker Mai, and Christopher R. BradenTable 2
Characteristics of CDI case-patients who had no identified risk factors, Maryland and Connecticut, USA, 2002−2007*
| Patient ID | Recruitment site | Age/sex | Race/ethnicity | Other medical conditions | Co-infections |
|---|---|---|---|---|---|
| 1 | Maryland | 62 y/M | White | Hypertension, GERD, COPD/asthma, depression/anxiety | |
| 2 | Maryland | 6 mo/M | White | Reflux | C. perfringens, rotavirus |
| 3 | Yale | 20 mo/M | Hispanic | None | Norovirus |
| 4 | Yale | 5 mo/M | White | None | |
| 5 | Yale | 28 y/F | Black | None | Rotavirus |
| 6 | Yale | 34 y/F | Hispanic | Polycystic ovary disease, diabetes, GERD | |
| 7 | Yale | 4 mo/M | Hispanic | None | Norovirus
*CDI, Clostridium difficile infection; GERD, gastroesophageal reflux disease; COPD, chronic obstructive pulmonary disease. *CDI, Clostridium difficile infection; GERD, gastroesophageal reflux disease; COPD, chronic obstructive pulmonary disease. |
*CDI, Clostridium difficile infection; GERD, gastroesophageal reflux disease; COPD, chronic obstructive pulmonary disease.
